The 2026 Healthtech Messaging Index
Paradigm
paradigmhealth.ai·scored September 1, 2026
15/38
Weak
The signal is faint. Most of this page is about Paradigm, not the buyer, and AI has little it can repeat. There's a lot of room to move.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for Clinical trial patient enrollment and site management solutions, it named:
Buyer we put in the prompt: Director of Research or VP of Clinical Operations at a hospital system, oncology practice, or pharmaceutical sponsor company. Both the buyer and the category were inferred from Paradigm’s homepage alone. The model had no web access.
Paradigm was not on the list.
A buyer who asked AI this question got 8 names and moved on. Paradigm never came up.
We asked AI who it recommends for "Director of Research or VP of Clinical Operations at a hospital system, oncology practice, or pharmaceutical sponsor company" looking for "Clinical trial patient enrollment and site management solutions". It named Medidata Solutions, Veeva Systems, ICON plc, Parexel, Syneos Health. You did not appear. AI can't recommend what it can't clearly understand.
Overall assessment
Paradigm Health's single biggest strength is the one concrete proof point ... a named customer (Highlands Oncology) with a real outcome (45% enrollment increase) and a titled testimonial ... which is more than most early-stage clinical research platforms show. The single biggest gap is solution clarity: after reading the entire homepage, a visitor still cannot explain in one sentence what Paradigm Health actually does, who it is specifically for, or how it works mechanically, making it nearly impossible for AI or a time-pressed buyer to recommend it with confidence.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
11Authority & Credibility
“No founder credentials, original research, frameworks, awards, or publications anywhere on the page.”
The page makes no attempt to establish authority ... no team bios with credentials, no cited research, no awards, no books or media mentions anywhere in the scraped content.
All 19 signals, scored 0 to 2.
Total 15/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“Clinical Research, Re-Engineered for Impact”
The headline gestures at clinical research but doesn't immediately name who it's for (sponsors? providers? patients?), what specific problem it solves, or what unique POV it takes ... a stranger can't answer all three in 7 seconds.
- 1
02Rebellion / Movement
“Paradigm Health is changing the model of clinical research”
There's an implicit enemy (the broken, slow, expensive status quo of clinical trials) but it's never named as an adversary ... the page says 'efficiency hasn't caught up to innovation' but never draws a line in the sand against a specific pattern or incumbent approach.
- 1
03Owned Language & Category
“orienting clinical trials around patient care”
There's a hint of a reframe (patient-centric trials) but it's not coined, capitalized, or owned as a named category, methodology, or framework that an AI would quote back distinctively.
- 1
04ICP Clarity
“For Sponsors" / "For Providers”
Two audiences are named but with zero specificity ... no company size, stage, vertical, or role title is mentioned, so a Director of Research at a mid-size CRO vs. a pharma sponsor VP cannot tell if this is meant for them.
- 1
05Problem Leadership
“The Race for Discovery Has Hurdles”
The page does surface industry-level problems (cost, time, enrollment failures) but leads with the company's mission statement, not the buyer's felt pain in their own words.
- 1
06Solution Clarity
“seamlessly combines technology and services, integrating directly with health provider organizations”
A visitor still cannot say in one sentence what Paradigm Health actually does ... 'technology and services' combined with 'integrating with providers' is too vague to repeat with confidence.
- 1
07Cost of Inaction
“80% Number of drugs that fail to meet enrollment targets" / "Average cost to develop a new drug”
Industry-level stakes are cited but the page never names the specific cost the buyer personally pays for not choosing Paradigm Health ... it's category pain, not consequence of inaction.
- 1
08Promised Land
“every patient has access to the latest care through clinical trials”
The promised land is painted at a societal/mission level, not as a concrete, specific 'after' state the individual buyer (sponsor or provider) will personally experience.
Trust Signal
4 signals
- 1
09Proof & Evidence
“Highlands increased clinical trial patient enrollment by 45% over the last two years”
There is one concrete delta (45% enrollment increase) but it stands alone with no other numbers, no before/after context for cost or time savings, and no second proof point to establish a pattern.
- 1
10Social Proof
“Adam Torres, BSBA, BSN, RN, CCRP ... Director of Research Development, Highlands Oncology”
There is exactly one named testimonial with title and company, which is better than nothing, but there are no additional logos, video stories, or case studies visible on the homepage.
- 0
11Authority & Credibilityweakest
“No founder credentials, original research, frameworks, awards, or publications anywhere on the page.”
The page makes no attempt to establish authority ... no team bios with credentials, no cited research, no awards, no books or media mentions anywhere in the scraped content.
- 0
12Alternatives Acknowledged
“No mention of competitors, alternative approaches, or 'do nothing' consequences anywhere on the page.”
The page completely ignores the buyer's alternatives ... no comparison to legacy CROs, in-house trial management, or the cost of maintaining the status quo is ever addressed.
AI Signal
6 signals
- 1
13Customer Focus
“By helping stakeholders connect dots and overcome complexities, we're making this vision a reality today”
The page oscillates between company mission and customer outcomes but the protagonist is mostly Paradigm Health's vision and model, not the customer's transformation journey.
- 1
14AI-Parmesan Index
“No 'AI-powered' claims found; domain is paradigmhealth.ai but the page doesn't lean on AI marketing language.”
The .ai domain could signal AI washing but the page doesn't actually make AI claims in the content, so it avoids the Parmesan trap ... however, the domain creates a false expectation that is never addressed or clarified.
- 1
15LLM Quotability
“Paradigm Health is changing the model of clinical research by orienting clinical trials around patient care”
There are quotable sentences but they're mission-speak rather than crisp, declarative, mechanistic claims an LLM could lift as a specific recommendation with confidence.
- 0
16Copyright Freshness
“© 2026 Paradigm Health. All rights reserved." ... No blog posts, case study dates, or recent content visible.”
The copyright year is 2026 (appears pre-dated or erroneous), and there are no dated blog posts or case studies on the homepage, removing any recency signal AI engines could weight.
- 1
17Entity Distinctiveness
“integrating directly with health provider organizations to fuel collaboration based on crucial insights”
The positioning has some distinctive elements (provider integration + sponsor service + patient-centric model) but swapping the logo for a generic CRO competitor would require minimal copy changes ... it's not unmistakably unique.
- 0
18AI Recommendation Check
“AI's picks: Medidata Solutions, Veeva Systems, ICON plc, Parexel, Syneos Health, ProSciento. You were not named.”
We asked AI who it recommends for "Director of Research or VP of Clinical Operations at a hospital system, oncology practice, or pharmaceutical sponsor company" looking for "Clinical trial patient enrollment and site management solutions". It named Medidata Solutions, Veeva Systems, ICON plc, Parexel, Syneos Health. You did not appear. AI can't recommend what it can't clearly understand.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“[For Sponsors]" / "[For Providers]" / "[Let's Connect]" / "[See How]”
There are multiple CTAs and two audience paths, but there's no numbered process showing what happens next, and the CTAs compete without a clear hierarchy between one primary action and one soft secondary.
Your move
Think Paradigm’s score is wrong? Good. Let’s look at it together.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Paradigm the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.